Deep Vein Thrombosis Segment to Dominate APAC Home Sequential Compression Devices Market during 2020–2028      

According to a new market research study on “APAC Home Sequential Compression Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Device Type, Type, and Application” is expected to reach US$ 347.75 million by 2028 from 211.60 US$ million in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021 to 2028. The report provides trends prevailing in the APAC home sequential compression devices market along with the drivers and restraints pertaining to the market growth. Sequential compression devices witness significant advancement is the major factor driving the growth of the APAC home sequential compression devices market. However, issues associated with various substitute therapies present hinders the growth of APAC home sequential compression devices market. 

 The APAC home sequential compression devices market is segmented on the bases of device type, type, application, and country. The APAC home sequential compression devices market, by type is segmented into alternate sequential compression device (ASCD), simultaneous sequential compression device (SSCD). The simultaneous sequential compression device (SSCD) segment held the largest share of the market in 2021. APAC home sequential compression devices market based on the type is segmented into standard and portable. In 2021, the standard segment is likely to hold the largest share of the market. The APAC home sequential compression devices market by application, is segmented into deep vein thrombosis (DVT), lymphedema management, chronic venous insufficiency (CVI) and others. The deep vein thrombosis (DVT), segment is likely to hold the largest share of the market in 2021. The APAC home sequential compression devices market, by country is segmented into Australia, China, India, Japan, and South Korea.   

Countries in APAC are facing challenges due to increasing incidences of COVID-19. As per the data of Worldometer, as of July 1st, 2021, in India the number of cases has been increasing and reached to 30,411,634 cases with 399,475 deaths. Japan has reported 798,159 confirmed cases and 14,740 deaths. Currently, India is the second worse hit country across the world. Many measures have been implemented to contain the spread of COVID-19, that have resulted in significant operational disruption for many companies including in home sequential compression devices manufacturing industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient for private hospital chains. To relieve healthcare systems, many clinics have been postponing non-critical procedures such as therapies for venous disorders. To avoid overburdening hospitals already struggling to deal with the rising pandemic pressure, doctors are recommending use of home care devices for patients suffering from venous disorders. Moreover, Medical device companies in APAC have started to forecast impact of pandemic in their business segments because people are staying at home. Various medical device companies such as Cardinal health have predicated the decline in sales in medical device segment due to the adverse impact of the COVID-19 pandemic, which was offset by sales growth from Cardinal Health at-Home Solutions such as home sequential compression systems. The countries such as India is conducting vaccination drive for the age group wise including the people within age group of 18–44, and 45 years and above. The country has also initiated testing of vaccine of the children, which is expected to bring some positive prospects for the medical device industry in the region. All these factors will support market growth for home sequential compression devices in APAC region.  

AIROS Medical; Arjo Medical Devices; Breg Inc.; Cardinal Health Inc; DJO Global, Inc.; DSMAREF CO.LTD; and Mego Afek ltd. are among the leading companies in the APAC home sequential compression devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Cardinal Health has acquired Medtronic's Patient Care, deep vein thrombosis (compression) and Nutritional Insufficiency business for $6.1 billion.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com